http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#Head
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#assertion
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#provenance
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#pubinfo
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#assertion
http://purl.obolibrary.org/obo/DOID_3798
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_3798
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01190
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association
http://www.w3.org/2000/01/rdf-schema#label
clindamycin is a lincosamide antibacterial indicated for the treatment of the following 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 limitation of use 1 9 to reduce the development of drug resistant bacteria and maintain the effectiveness of clindamycin in 9 sodium chloride injection and other antibacterial drugs clindamycin in 9 sodium chloride injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria 1 1 clindamycin in 9 sodium chloride injection is indicated for the treatment of serious infections caused by susceptible anaerobic bacteria see indications and usage 1 3 1 7 clindamycin in 9 sodium chloride injection is indicated for the treatment of serious infections due to susceptible strains of streptococci pneumococci and staphylococci its use should be reserved for penicillin allergic patients or other patients for whom in the judgment of the physician a penicillin is inappropriate because of the risk of antibacterial associated pseudomembranous colitis see boxed warning bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin indicated surgical procedures should be performed in conjunction with antibacterial therapy clindamycin in 9 sodium chloride injection is indicated in the treatment of serious lower respiratory tract infections including pneumonia empyema and lung abscess caused by susceptible strains of anaerobes streptococcus pneumoniae e faecalis staphylococcus aureus clindamycin in 9 sodium chloride injection is indicated in the treatment of serious skin and skin structure infections caused by susceptible strains of streptococcus pyogenes staphylococcus aureus clindamycin in 9 sodium chloride injection is indicated in the treatment of serious gynecological infections including endometritis nongonococcal tubo ovarian abscess pelvic cellulitis and postsurgical vaginal cuff infection caused by susceptible anaerobes clindamycin in 9 sodium chloride injection is indicated in the treatment of serious intra abdominal infections including peritonitis and intra abdominal abscess caused by susceptible anaerobic organisms clindamycin in 9 sodium chloride injection is indicated in the treatment of serious septicemia caused by susceptible strains of staphylococcus aureus enterococcus faecalis clindamycin in 9 sodium chloride injection is indicated in the treatment of serious bone and joint infections including acute hematogenous osteomyelitis caused by susceptible strains of staphylococcus aureus since clindamycin does not diffuse adequately into the cerebrospinal fluid clindamycin in 9 sodium chloride injection should not be used in the treatment of meningitis see clinical pharmacology 12 3 to reduce the development of drug resistant bacteria and maintain the effectiveness of clindamycin in 9 sodium chloride injection and other antibacterial drugs clindamycin in 9 sodium chloride injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB01190
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#provenance
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#pubinfo
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#sig
http://purl.org/nanopub/x/hasSignature
aVacqxqfyDU0AZvWkfLgubOF8hCCPS7ivPeUOgDcEFDZxO1FY0nC92zF10I1YH5PeLQbCUvxeZUWCbvFUDM3pgWNc+64JnX1Una3QR6VTgnlDe/VmP0C1SJH9KtHGBCP0h5KXPHWBHYTCvp+Up/mW2F1faU7WO3EFYAnzM9X/Dg=
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0
http://purl.org/dc/terms/created
2021-06-12T15:16:41.107+02:00
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs